CORONAVIRUS DISEASE 2019
Clinical trials for CORONAVIRUS DISEASE 2019 explained in plain language.
Never miss a new study
Get alerted when new CORONAVIRUS DISEASE 2019 trials appear
Sign up with your email to follow new studies for CORONAVIRUS DISEASE 2019, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug leronlimab tested in severe COVID-19 patients
Disease control CompletedThis study tested a drug called leronlimab in 484 hospitalized adults with severe or critical COVID-19. Participants received weekly injections of either leronlimab or a placebo. The main goal was to see if the drug could reduce deaths by day 28 and improve recovery.
Matched conditions: CORONAVIRUS DISEASE 2019
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
Scientists probe why COVID-19 wipes out key immune cells
Knowledge-focused CompletedThis study looked at how the virus that causes COVID-19 affects lymphocytes, a type of white blood cell that fights infection. Researchers studied 240 adults who had or recently recovered from COVID-19. They collected blood samples and medical records to learn more about the immu…
Matched conditions: CORONAVIRUS DISEASE 2019
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 26, 2026 06:56 UTC
-
Adaptive COVID-19 drug combo trial wraps up
Knowledge-focused CompletedThis completed Phase 2 trial tested the safety and effectiveness of different drug combinations in people with COVID-19. It used a master protocol that allowed both hospitalized and non-hospitalized patients to join. Only 4 participants were enrolled, and the study focused on mea…
Matched conditions: CORONAVIRUS DISEASE 2019
Phase: PHASE2 • Sponsor: Leidos Life Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 06:49 UTC